A Randomized, Open-label, 3-way Crossover Clinical Trial to Compare The Pharmacokinetics of A Pregabalin Controlled Release Tablet 300mg With Immediate Release Formulation and to Assess the Effect of High Fat Diet in Healthy Male Subjects
Latest Information Update: 31 May 2017
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Pharmacokinetics
- Sponsors Ildong Pharmaceutical
Most Recent Events
- 21 May 2014 New trial record